Hjem › Alvorlig depressiv lidelse › Oklahoma
Alvorlig depressiv lidelse kliniske forsøg i Oklahoma
12 studier for Alvorlig depressiv lidelse søger deltagere på steder i Oklahoma.
Byer i Oklahoma
Officiel studietekst (engelsk)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Conrad Clinical Research, Edmond
- Sooner Clinical Research, Oklahoma City
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 1. okt. 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Conrad Clinical Research, Edmond
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 25. sep. 2026 · NCT06559306A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Sooner Clinical Research, Oklahoma City
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 8. sep. 2026 · NCT07076407A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Pahl Pharmaceutical Professionals Llc, Oklahoma City
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 3. aug. 2026 · NCT06775379A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Edmond
- Neurocrine Clinical Site, Oklahoma City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Edmond
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Edmond
- Clinical Research Site, Oklahoma City
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 24. jul. 2026 · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Sooner Clinical Research /ID# 277659, Oklahoma City
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 15. jun. 2026 · NCT07276997Neural Response to Inflammatory Challenge in Major Depressive Disorder
- Laureate Institute for Brain Research, Tulsa
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 21. apr. 2026 · NCT04751331Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #107, Oklahoma City
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 20. jan. 2026 · NCT06633016Study of ALTO-300 in MDD
- Site 195, Oklahoma City
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 24. jul. 2025 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Edmond
- Clinical Research Site, Oklahoma City
RekruttererFase 4
Alder 18 til 65 · Alle køn · Opdateret 23. jan. 2025 · NCT06223880Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.